ONCSQ (OncoSec Medical) Pre-Tax Income: $-32.72 Mil (TTM As of Jan. 2023)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is OncoSec Medical Pre-Tax Income?

OncoSec Medical ONCSQ -90.00% Pre-Tax Income is $-32.72 Mil as of Jan. 2023.

Pretax income is the income that a company earns before paying income taxes. OncoSec Medical's pretax income for the three months ended in Jan. 2023 was $-6.86 Mil. Its pretax income for the trailing twelve months (TTM) ended in Jan. 2023 was $-32.72 Mil. OncoSec Medical's pretax margin was %.

OncoSec Medical  (OTCPK:ONCSQ) Pre-Tax Income Explanation

OncoSec Medical's Pretax Margin for the quarter that ended in Jan. 2023 is calculated as

Pretax Margin=Pretax Income/Revenue
=-6.858/0
=%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Pre-Tax Income Related Terms

OncoSec Medical Pre-Tax Income Historical Data

* Premium members only.

The historical data trend for OncoSec Medical's Pre-Tax Income can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoSec Medical Pre-Tax Income Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Pre-Tax Income
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.14 -30.28 -43.13 -47.58 -37.51

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Pre-Tax Income Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -9.90 -9.58 -8.22 -8.06 -6.86

ONCSQ vs NOVNQ, USRM, VRTX: Pre-Tax Income Comparison

For the Biotechnology subindustry, OncoSec Medical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

OncoSec Medical Pre-Tax Income vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, OncoSec Medical's Pre-Tax Income distribution charts can be found below:

* The bar in red indicates where OncoSec Medical's Pre-Tax Income falls into.


OncoSec Medical Pre-Tax Income Calculation

This is the income that a company earns before paying income taxes.

OncoSec Medical's Pretax Income for the fiscal year that ended in Jul. 2022 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-37.012+-0.481+-0.021+0+0
=-37.51

OncoSec Medical's Pretax Income for the quarter that ended in Jan. 2023 is calculated as

Pretax Income=Operating Income+Non Operating Income+Interest Expense+Interest Income+Other
=-7.664+0.839+-0.034+0+0.0010000000000003
=-6.86

Pre-Tax Income for the trailing twelve months (TTM) ended in Jan. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-32.72 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Pre-Tax Income →
What does a Pre-Tax Income of $-32.72 Mil mean?
OncoSec Medical (ONCSQ) has a Pre-Tax Income of $-32.72 Mil as of Jan. 2023. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on OncoSec Medical and its competitors.
Is OncoSec Medical's Pre-Tax Income too high?
OncoSec Medical's current Pre-Tax Income is $-32.72 Mil.
How does OncoSec Medical's Pre-Tax Income compare to NOVNQ and USRM?
OncoSec Medical's Pre-Tax Income of $-32.72 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Pre-Tax Income for a Biotechnology company?
A good Pre-Tax Income depends on the Biotechnology industry context. However, Pre-Tax Income should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Pre-Tax Income mean?
A high Pre-Tax Income can signal that a stock is expensive relative to its fundamentals. Pre-Tax Income is the total earnings before taxes but after all operating and interest expenses. View historical data on OncoSec Medical and its competitors. OncoSec Medical's current Pre-Tax Income is $-32.72 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoSec Medical stock overvalued right now?
OncoSec Medical (ONCSQ) has a current Pre-Tax Income of $-32.72 Mil. The current Pre-Tax Income is $-32.72 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Pre-Tax Income calculated?
Pre-Tax Income is calculated from a company's financial statements. For OncoSec Medical (ONCSQ), the current Pre-Tax Income is $-32.72 Mil as of Jan. 2023. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

OncoSec Medical Business Description

Address 820 Bear Tavern Road, Ewing, NJ, USA, 08628-1021
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.